Announcements
- ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC
- ONWARD® Medical Announces Participation in Stifel European Healthcare Summit
- ONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe Conference
- ONWARD® Medical Announces Results of Annual General Meeting of Shareholders
- ONWARD® Medical fait le point sur le premier trimestre 2024 et sur les faits marquants de l’année écoulée
- ONWARD® Medical berichtet über das 1. Quartal 2024 und die bisherigen Höhepunkte des Jahres
- ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights
- ONWARD® Medical veranstaltet Webcast zu Einzelheiten der Up-LIFT-Studie und der aktuellen Veröffentlichung in Nature Medicine
- ONWARD® Medical organise une téléconférence pour partager les détails relatifs à son étude clinique Up-LIFT et à sa publication dans la revue Nature Medicine
- Nature Medicine se réjouit de partager l’amélioration significative de la fonction de la main et du bras après une lésion de la moelle épinière grâce à la thérapie ONWARD® ARC-EX® Therapy
More ▼
Key statistics
As of last trade, ONWARD Medical NV (63E:DUS) traded at 4.89, 13.72% above the 52 week low of 4.30 set on Feb 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.89 |
---|---|
High | 4.89 |
Low | 4.89 |
Bid | 4.89 |
Offer | 5.20 |
Previous close | 4.91 |
Average volume | 0.00 |
---|---|
Shares outstanding | 34.63m |
Free float | 28.07m |
P/E (TTM) | -- |
Market cap | 177.30m EUR |
EPS (TTM) | -1.20 EUR |
Data delayed at least 15 minutes, as of Jul 04 2024 07:12 BST.
More ▼